Cargando…
Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair
Hallmarks of cancer cells include uncontrolled growth and rapid proliferation; thus, cyclin-dependent kinases are a therapeutic target for cancer treatment. Treating non-small lung cancer cells with sublethal concentrations of the CDK4/6 inhibitors, ribociclib (LEE011) and palbociclib (PD0332991), w...
Autores principales: | Tempka, Dominika, Tokarz, Paulina, Chmielewska, Kinga, Kluska, Magdalena, Pietrzak, Julita, Rygielska, Żaneta, Virág, László, Robaszkiewicz, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975074/ https://www.ncbi.nlm.nih.gov/pubmed/29306194 http://dx.doi.org/10.1016/j.redox.2017.12.017 |
Ejemplares similares
-
PARP1 promoter links cell cycle progression with adaptation to oxidative environment
por: Pietrzak, Julita, et al.
Publicado: (2018) -
PARP Traps Rescue the Pro-Inflammatory Response of Human Macrophages in the In Vitro Model of LPS-Induced Tolerance
por: Pietrzak, Julita, et al.
Publicado: (2021) -
PARP1 and OGG1 in Medicated Patients With Depression and the Response to ECT
por: Ryan, Karen M, et al.
Publicado: (2022) -
OGG1 in the Kidney: Beyond Base Excision Repair
por: Zhao, Fan, et al.
Publicado: (2022) -
PARP-1 Expression is Increased in Colon Adenoma and Carcinoma and Correlates with OGG1
por: Dziaman, Tomasz, et al.
Publicado: (2014)